Indian Pharmaceutical Alliance

Intas focuses on creating sustainable and affordable health and socio-economic opportunities for people. It has touched 160,000 lives through the Patient Assistance Program and over 578,000 beneficiaries have benefitted through the Blood Bank Upliftment Program.

Learn more about CSR initiatives by Intas and other IPA member companies in our latest report, ‘Deepening The Responsible Business Agenda’, in collaboration with Samhita.

Download the report here: https://t.co/t5ce36HrmO

Glenmark Pharmaceuticals believes that investing in children's health is crucial for the future. Glenmark has implemented numerous CSR programs aimed at enhancing nutrition, sanitation and immunisation. Over 2,200,000 children have received support through these initiatives.

Know more about CSR initiatives by Glenmark and other IPA member companies in our latest report, ‘Deepening The Responsible Agenda’ in collaboration with Samhita.

Download the report: https://bit.ly/3w1jPQc

Emcure Pharmaceuticals Limited has contributed to the holistic development of the unprivileged community through talent development in children, free health check-ups and disease detection camps. It has also supported anaemia prevention in women across India.

Know more about CSR initiatives by Emcure and other IPA member companies in our latest report, 'Deepening The Responsible Business Agenda' in collaboration with Samhita.

Download the report: https://bit.ly/3w1jPQc

Dr. Reddy's Laboratories Ltd. has actively contributed to sustainable community development through various initiatives targeting youth, the specially-abled, and rural communities, positively impacting 331,861 individuals through its CSR activities.

Learn more about Dr. Reddy's contributions and those of other IPA member companies in our latest report, 'Deepening The Responsible Agenda,' prepared in collaboration with Samhita.

Download the report here: https://bit.ly/3w1jPQc

Cipla Foundation is driven by a commitment to empower vulnerable communities through its CSR initiatives. It has touched the lives of over 1,50,000 individuals through health and education programs.

Explore the contributions of Cipla and other IPA member companies in our latest report, 'Deepening The Responsible Business Agenda,' in collaboration with Samhita.

Download the report: https://bit.ly/3w1jPQc

Cadila Pharmaceuticals Ltd. endeavours to address social, economic and environmental challenges through its CSR initiatives. Over 1 million individuals have received treatment at nominal or no cost, while more than 26,000 impoverished patients have benefited from free dialysis services, including pickup and drop facilities, as part of Cadila's programs.

Know more about CSR initiatives by Cadila and other IPA member companies in our latest report, 'Deepening The Responsible Business Agenda' in collaboration with Samhita.

Download the report: https://bit.ly/3w1jPQc

In pursuit of giving back to society, Aurobindo Pharma has reached out to 1.84 lakh students, benefiting them through various education projects, and helped 16,102 farmers in undertaking sustainable agricultural practices through lift irrigation facilities.

Know more about CSR initiatives by Aurobindo and other member companies in our latest report, 'Deepening The Responsible Business Agenda' in collaboration with Samhita.

Download the report for more: https://bit.ly/3w1jPQc

ALKEM Laboratories Ltd. has undertaken various initiatives to empower women with skills and eradicate anaemia from rural areas. Additionally, it has successfully implemented zero liquid discharge facilities in 64% of its manufacturing units.

Learn more about Alkem's and other IPA companies' CSR initiatives in our latest report, 'Deepening The Responsible Business Agenda,' in partnership with Samhita.

Download the report for further insights: https://bit.ly/3w1jPQc

Alembic Pharmaceuticals Ltd is focusing on improving health, education, livelihood, environment, art and culture.

Discover the key CSR initiatives by Alembic and other IPA Member Companies in our latest report in collaboration with Samhita.

Download the report for more details here: https://bit.ly/3w1jPQc

Ajanta Pharma Ltd.'s mission is to serve global healthcare needs through empathy, innovation, and technology. Through various CSR initiatives, they have positively impacted over 2 million individuals through healthcare programs.

Explore our latest industry report, "Deepening the Responsible Business Agenda," in partnership with Samhita, to delve into Ajanta's contributions.

Download the report now: https://bit.ly/3w1jPQc

Abbott's citizenship programs aim to make healthcare more accessible, enhance school facilities, and promote STEM education. Through their various initiatives, Abbott has already helped over 55,000 people.

Our latest report, 'Deepening The Responsible Business Agenda,' created in collaboration with Samhita, explores the impactful changes made by Abbott and many other IPA member companies.

Download the report here: https://bit.ly/3w1jPQc

We are pleased to announce the official launch of our latest report, in collaboration with Samhita, titled 'Deepening The Responsible Business Agenda'.

This report explores the CSR and ESG initiatives undertaken by IPA companies, advocating for a Responsible Business Agenda.

Download the report: https://bit.ly/3w1jPQc

Join us for the launch of our latest report titled, ‘Deepening The Responsible Business Agenda,’ in collaboration with Samhita at 02.30 p.m. today!

This report explores the CSR and ESG initiatives undertaken by IPA companies, advocating for a Responsible Business Agenda.

Use the below links to join us for the launch event.

Zoom Details:
https://zoom.us/j/97590384714?pwd=eW9DbDQ1OWwzdHhteldPcmpvUlFhQT09
Passcode: 207085

YouTube Live Link:
https://youtube.com/live/X4cCAprwKto?feature=share

Dr. Reddy's Laboratories Ltd. | Sun Pharmaceutical Industries Limited

IPA member companies have impacted over 15 million beneficiaries, including newborns, pregnant women, and disabled with initiatives in community health, education, and livelihood, across the nation. Know the details about the various CSR programs in our upcoming report ‘Deepening The Responsible Business Agenda,' in partnership with Samhita.

Get ready for the launch of our 2nd CSR Report titled 'Deepening the Responsible Business Agenda,' in association with Samhita. The countdown is on, with just one day left until the official launch.

As India celebrates its 75th Republic Day, let us also acknowledge the contributions of Indian pharma sector, a driving force in our journey towards building a healthier and stronger nation. We wish a Happy Republic Day to all of you!

We are pleased to announce the launch of our latest CSR knowledge report in collaboration with Samhita. Building on our 2019 report, this new edition delves deeper into the CSR and ESG initiatives of the Indian pharmaceutical industry.

Link to the previous report: https://bit.ly/3S4yyB6

Save the Date!

Join us for the launch of our latest report titled, 'Deepening The Responsible Business Agenda,' in collaboration with Samhita Building on our 2019 report, this edition highlights the CSR and ESG impact initiatives taken up by the Indian
pharmaceutical industry. More details coming soon!

Mr. Sudarshan Jain, Secretary General - Indian Pharmaceutical Alliance, was invited to the panel discussion 'Future Frontier in Indian Healthcare: Innovating for a Healthier Tomorrow' at the Wharton India Economic Forum 2024.

He emphasized that Quality is of fundamental importance for Indian pharma and highlighted that the recent announcement of revised Schedule M will propel India’s journey to become a global benchmark in Quality. Furthermore, he underscored that the entrepreneurial spirit and policy interventions have played a key role in shaping the industry and emphasised the thrust on innovation to move up from Volume to Value leadership.

Sudarshan Jain – Secretary General, Indian Pharmaceutical Alliance, in conversation with Pharma Boardroom, talks about the pivotal role IPA plays in representing the interests of 25 leading Indian pharmaceutical companies, both domestically and internationally.

He shared his insights on how India, with its diverse population, increasing use of digital technology, and commitment to democracy, is becoming a significant player in healthcare innovation worldwide.

Read more here: https://bit.ly/3Rx7xq1

In his interview with BusinessWorld Healthcare, Mr Sudarshan Jain, Secretary General - IPA, highlights Indian pharma industry's outlook, R&D investments, medical device policies, and measures for strengthening quality agenda.

Our Managing Director, Dilip Shanghvi penned an article for Mint on how our country can strengthen the regulatory framework for the Indian pharmaceutical industry, enabling it to achieve its full potential.

The wait is over - only 1 day to go!

The 8th Advanced GMP Workshop is almost here! The Workshop will witness sessions and panel discussions from industry leaders, experts and regulators around the world!

Last chance to register!

Register now: https://bit.ly/3PPi9AX

2 Days To Go!

Register today and secure your spot in the 8th Advanced GMP Workshop 2023.

Register now: https://bit.ly/3PPi9AX

Mr. Sudarshan Jain, Secretary General, IPA, participated in the Innovate India, Vision 2047 Conference organized by OPPI. The conference was focused on fostering innovation in India and brought together key healthcare leaders and policymakers.

Only 3 days left until the 8th Advanced GMP Workshop. This workshop offers a unique opportunity to engage with Subject Matter Experts from global regulatory bodies and industry.

Register now: https://bit.ly/3PPi9AX

Dr Carmelo Rosa, Director, Division of Drug Quality, CDER/OMQ, FDA, will share insights on best practices of responding to FDA 483 Inspection observations on Day 1 of the 8th Advanced GMP Workshop.

Register now: https://bit.ly/3PPi9AX

Opportunity to engage with Subject Matter Experts from global regulatory bodies like the USFDA, CDSCO, and MHRA, alongside seasoned industry professionals and consultants. Block your calendar on 03-04 October for the 8th Advanced GMP Workshop 2023.

Register for the event here: https://bit.ly/3PPi9AX

Join us on 03-04 October 2023 for the 8th Advanced GMP Workshop, where global regulators, industry experts and consultants will cover diverse topics on Quality Culture, Best Practices Sharing in Key Areas of Quality, Transformation through Gen AI, and Future-Ready Themes.

Register for the event here: https://bit.ly/3PPi9AX

IPA celebrates the essential role pharmacists play in the healthcare system. The dedication and expertise of pharmacists are instrumental in providing safe and effective medicines, contributing to patients worldwide.